Literature DB >> 31844000

100 Years of Suramin.

Natalie Wiedemar1,2, Dennis A Hauser1,2, Pascal Mäser3,2.   

Abstract

Suramin is 100 years old and is still being used to treat the first stage of acute human sleeping sickness, caused by Trypanosoma brucei rhodesiense Suramin is a multifunctional molecule with a wide array of potential applications, from parasitic and viral diseases to cancer, snakebite, and autism. Suramin is also an enigmatic molecule: What are its targets? How does it get into cells in the first place? Here, we provide an overview of the many different candidate targets of suramin and discuss its modes of action and routes of cellular uptake. We reason that, once the polypharmacology of suramin is understood at the molecular level, new, more specific, and less toxic molecules can be identified for the numerous potential applications of suramin.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  Trypanosoma brucei; human African trypanosomiasis; polypharmacology; sleeping sickness; suramin

Mesh:

Substances:

Year:  2020        PMID: 31844000      PMCID: PMC7038244          DOI: 10.1128/AAC.01168-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  184 in total

1.  Inhibition of streptococcal bacteriophage by suramin.

Authors:  B REITER; J D ORAM
Journal:  Nature       Date:  1962-02-17       Impact factor: 49.962

2.  Inhibition of hyaluronidase action by derivatives of hesperidin.

Authors:  J M BEILER; G J MARTIN
Journal:  J Biol Chem       Date:  1948-05       Impact factor: 5.157

3.  The trypanocidal drug suramin and other trypan blue mimetics are inhibitors of pyruvate kinases and bind to the adenosine site.

Authors:  Hugh P Morgan; Iain W McNae; Matthew W Nowicki; Wenhe Zhong; Paul A M Michels; Douglas S Auld; Linda A Fothergill-Gilmore; Malcolm D Walkinshaw
Journal:  J Biol Chem       Date:  2011-07-05       Impact factor: 5.157

4.  A phase I study of intravesical suramin for the treatment of superficial transitional cell carcinoma of the bladder.

Authors:  Edward M Uchio; W Marston Linehan; William D Figg; McClellan M Walther
Journal:  J Urol       Date:  2003-01       Impact factor: 7.450

5.  Suramin interaction with human alpha-thrombin: inhibitory effects and binding studies.

Authors:  Robson Q Monteiro; Patricia T Campana; Paulo A Melo; M Lucia Bianconi
Journal:  Int J Biochem Cell Biol       Date:  2004-10       Impact factor: 5.085

6.  Uptake of the trypanocidal drug suramin by bloodstream forms of Trypanosoma brucei and its effect on respiration and growth rate in vivo.

Authors:  A H Fairlamb; I B Bowman
Journal:  Mol Biochem Parasitol       Date:  1980-10       Impact factor: 1.759

7.  Experimental animal model for mucopolysaccharidosis: suramin-induced glycosaminoglycan and sphingolipid accumulation in the rat.

Authors:  G Constantopoulos; S Rees; B G Cragg; J A Barranger; R O Brady
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

8.  Suramin interacts with the positively charged region surrounding the 5-fold axis of the EV-A71 capsid and inhibits multiple enterovirus A.

Authors:  Peijun Ren; Yimei Zheng; Wenqi Wang; Liping Hong; Françis Delpeyroux; Fernando Arenzana-Seisdedos; Ralf Altmeyer
Journal:  Sci Rep       Date:  2017-02-20       Impact factor: 4.379

9.  Structural and functional characterization of suramin-bound MjTX-I from Bothrops moojeni suggests a particular myotoxic mechanism.

Authors:  Guilherme H M Salvador; Thiago R Dreyer; Antoniel A S Gomes; Walter L G Cavalcante; Juliana I Dos Santos; César A Gandin; Mário de Oliveira Neto; Márcia Gallacci; Marcos R M Fontes
Journal:  Sci Rep       Date:  2018-07-09       Impact factor: 4.379

10.  Identification and analysis of hepatitis C virus NS3 helicase inhibitors using nucleic acid binding assays.

Authors:  Sourav Mukherjee; Alicia M Hanson; William R Shadrick; Jean Ndjomou; Noreena L Sweeney; John J Hernandez; Diana Bartczak; Kelin Li; Kevin J Frankowski; Julie A Heck; Leggy A Arnold; Frank J Schoenen; David N Frick
Journal:  Nucleic Acids Res       Date:  2012-06-27       Impact factor: 16.971

View more
  27 in total

1.  Structural basis for inhibition of the SARS-CoV-2 RNA polymerase by suramin.

Authors:  Wanchao Yin; Xiaodong Luan; Zhihai Li; Ziwei Zhou; Qingxing Wang; Minqi Gao; Xiaoxi Wang; Fulai Zhou; Jingjing Shi; Erli You; Mingliang Liu; Qingxia Wang; Yi Jiang; Hualiang Jiang; Gengfu Xiao; Leike Zhang; Xuekui Yu; Shuyang Zhang; H Eric Xu
Journal:  Nat Struct Mol Biol       Date:  2021-03-05       Impact factor: 15.369

Review 2.  Trypanosoma brucei: Metabolomics for analysis of cellular metabolism and drug discovery.

Authors:  Fanta Fall; Lucia Mamede; Laura Schioppa; Allison Ledoux; Pascal De Tullio; Paul Michels; Michel Frédérich; Joëlle Quetin-Leclercq
Journal:  Metabolomics       Date:  2022-03-19       Impact factor: 4.290

3.  Inhibition of RNA Binding in SND1 Increases the Levels of miR-1-3p and Sensitizes Cancer Cells to Navitoclax.

Authors:  Saara Lehmusvaara; Teemu Haikarainen; Juha Saarikettu; Guillermo Martinez Nieto; Olli Silvennoinen
Journal:  Cancers (Basel)       Date:  2022-06-24       Impact factor: 6.575

4.  Enterovirus A71 antivirals: Past, present, and future.

Authors:  Jun Wang; Yanmei Hu; Madeleine Zheng
Journal:  Acta Pharm Sin B       Date:  2021-08-20       Impact factor: 14.903

5.  The Error-Prone Polymerase DnaE2 Mediates the Evolution of Antibiotic Resistance in Persister Mycobacterial Cells.

Authors:  S Salini; Sinchana G Bhat; Saba Naz; Ramanathan Natesh; R Ajay Kumar; Vinay Kumar Nandicoori; Krishna Kurthkoti
Journal:  Antimicrob Agents Chemother       Date:  2022-03-15       Impact factor: 5.938

6.  A T5 Exonuclease-Based Assay for DNA Topoisomerases and DNA Intercalators.

Authors:  Zifang Deng; Fenfei Leng
Journal:  ACS Omega       Date:  2021-04-28

7.  Structural Basis of Inhibition of the Pioneer Transcription Factor NF-Y by Suramin.

Authors:  Valentina Nardone; Antonio Chaves-Sanjuan; Michela Lapi; Cristina Airoldi; Andrea Saponaro; Sebastiano Pasqualato; Diletta Dolfini; Carlo Camilloni; Andrea Bernardini; Nerina Gnesutta; Roberto Mantovani; Marco Nardini
Journal:  Cells       Date:  2020-10-29       Impact factor: 6.600

8.  Identification of HMGA2 inhibitors by AlphaScreen-based ultra-high-throughput screening assays.

Authors:  Linjia Su; Nadezda Bryan; Sabrina Battista; Juliano Freitas; Alyssa Garabedian; Federica D'Alessio; Miriam Romano; Fabiana Falanga; Alfredo Fusco; Lidia Kos; Jeremy Chambers; Francisco Fernandez-Lima; Prem P Chapagain; Stefan Vasile; Layton Smith; Fenfei Leng
Journal:  Sci Rep       Date:  2020-11-02       Impact factor: 4.379

Review 9.  Recent advances in urea- and thiourea-containing compounds: focus on innovative approaches in medicinal chemistry and organic synthesis.

Authors:  Riccardo Ronchetti; Giada Moroni; Andrea Carotti; Antimo Gioiello; Emidio Camaioni
Journal:  RSC Med Chem       Date:  2021-05-13

10.  Controlling Peptide Function by Directed Assembly Formation: Mechanistic Insights Using Multiscale Modeling on an Antimicrobial Peptide-Drug-Membrane System.

Authors:  Gergely Kohut; Tünde Juhász; Mayra Quemé-Peña; Szilvia Erika Bősze; Tamás Beke-Somfai
Journal:  ACS Omega       Date:  2021-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.